Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

EB Pharma Announces License Agreement for Investigational Drug, Tipifarnib from Janssen Pharmaceutica for Development in Hepatitis Delta Virus (HDV) Infection

Canada NewsWire December 23, 2014

BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection

GlobeNewswire December 23, 2014

Provectus Biopharmaceuticals' Protocol for Phase 2 Study of Mechanism of Action of PH-10 on Immunologic Makers of Psoriasis Now Available Online

Business Wire December 23, 2014

Alcon treatment Travatan® receives EU approval for pediatric glaucoma patients

Thomson Reuters ONE December 23, 2014

Acucela Announces That Brian O'Callaghan Will Assume the Role of CEO; Ryo Kubota, M.D., Ph.D., to Remain Chairman of the Board

Business Wire December 22, 2014

Scientists predict worst coral bleaching in 20 years

UPI December 22, 2014

One in Every Three People with Type 1 Diabetes Produces Insulin Years Post-Diagnosis

PR Newswire December 22, 2014

Bristol-Myers Squibb Receives Accelerated Approval of Opdivo (nivolumab) from the U.S. Food and Drug Administration

Business Wire December 22, 2014

Aeolus Announces Fiscal Year 2014 Financial Results

Marketwired December 22, 2014

NIA Magellan, InformedDNA to Offer Genetic Benefits Optimization Solution

Business Wire December 22, 2014

Medivation Exercises License Option for Pidilizumab

Marketwired December 22, 2014

Auspex Added to the NASDAQ Biotechnology Index

GlobeNewswire December 22, 2014

Mitogenetics Revolutionizes How People Manage Diseases

Marketwired December 22, 2014

South Dakota Based Mitogenetics Revolutionizes How People Manage Diseases

Marketwired December 22, 2014

Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck

GlobeNewswire December 22, 2014

Scripps Research Institute Scientists Uncover New, Fundamental Mechanism for How Resveratrol Provides Health Benefits

PR Newswire December 22, 2014

The World Market for Tissue Diagnostics and Cell-Based Diagnostics (HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other Tests)

PR Newswire December 22, 2014

BrainStorm Cell Therapeutics to Host Conference Call to Discuss Final Results of Phase 2a Trial of NurOwn(TM) in ALS on January 5, 2015

PR Newswire December 22, 2014

Bioheart Announces Completion of First Stem Cell Training in Australia

Accesswire December 22, 2014

New Corn Yield World Record Set with DEKALB

Business Wire December 22, 2014